// App-Quantinova.ai

2323 : HMGA1, a Factor Enriched in Hematopoietic Stem Cells, Embryonic Stem Cells, and Hematologic Malignancy, Enhances Cellular Reprogramming to a Pluripotent Stem-Like Cell.

Researchers

Presenter

  • Sandeep N Shah

Principal Investigators

  • Candace Kerr

  • Leslie Cope

  • Elias Zambidis

  • Amy Belton

  • David L. Huso

Medical Centers

  • Department of Medicine, Hematology Division, Johns Hopkins University School of Medicine, Baltimore, MD, USA,

  • The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Hematological malignancies

  • Solid malignancies

  • Teratoma

Biomarkers

  • Kruppel-like factor 4

  • SRY-Box 2

Drug/Treatment

  • Methadone hydrochloride

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim